Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

RecruitingOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

March 5, 2018

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Facioscapulohumeral Muscular Dystrophy
Interventions
DIAGNOSTIC_TEST

FSHD-specific functional rating scale

The FSHD-COM is composed of disease-relevant functional tasks such as leg function; shoulder and arm function; trunk function, hand function, and balance.

DEVICE

Electrical Impedance Myography

EIM is a non-invasive, painless, and fast technique for obtaining information on how a patient's muscle structure is changing. EIM uses a small electrical current to measure the health of the underlying muscle. The patient will be asked to lie down and a trained clinical evaluator will perform testing on 16 total muscles (8 on each side) on your arms and legs.

Trial Locations (14)

14642

COMPLETED

University of Rochester Medical Center, Rochester

20162

RECRUITING

Centro Clinico NeMO, Milan

21205

COMPLETED

Kennedy Krieger Institute, Baltimore

23298

COMPLETED

Virginia Commonwealth University, Richmond

43210

COMPLETED

The Ohio State University, Columbus

66160

COMPLETED

University of Kansas Medical Center, Kansas City

75013

RECRUITING

Institut de Myologie, Paris

80336

RECRUITING

Ludwig-Maximilians-Universität München, München

84132

COMPLETED

University of Utah, Salt Lake City

90095

COMPLETED

University of California Los Angeles, Los Angeles

98195

COMPLETED

University of Washington, Seattle

06001

ACTIVE_NOT_RECRUITING

Chu De Nice, Nice

6525 XZ

COMPLETED

Radboud Unviersity, Nijmegen

WC1N 3BG

RECRUITING

University of College London - Queens Square, London

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

FSHD Society

OTHER

collaborator

Friends Research Institute, Inc.

OTHER

collaborator

Muscular Dystrophy Association

OTHER

collaborator

AFM Telethon

UNKNOWN

collaborator

University of Rochester

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

Dyne Therapeutics

INDUSTRY

lead

University of Kansas Medical Center

OTHER